Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 July 2022 | Story Andre Damons | Photo Supplied
Prof Martie Smith and Prof Drik Opperman
Prof Martie Smit and Prof Dirk Opperman in the Department of Microbiology and Biochemistry filed a patent entitled “Process for the chemical modification of alkanes, fatty acids and fatty alcohols”.

Flavours and fragrances have a wide application in the food, feed, cosmetic, chemical and pharmaceutical sectors. Many flavour compounds are still produced via chemical synthesis or via extraction from plant or animal sources. However, there is increasing interest in their bio-production or the use of flavour compounds of (micro) biological origin. 

One reason for this shift is that chemical synthesis often uses environmentally unfriendly processes. Chemical synthesis usually also produces racemic mixtures with the second enantiomer, mirror image of the looked-for compound, often having undesirable organoleptic properties. Furthermore, the consumer has developed a “chemophobia”-attitude towards synthetic chemical compounds, especially when related to food and home-care products.  This applies even to nature-identical compounds – products that occur in nature but are produced via a non-natural chemical process. Products produced with the use of enzymes or microbes from “natural” substrates can be labelled “natural”. The flavour and fragrance industry thus pay higher prices for such products labelled as “natural”.  

The invention

A University of the Free State (UFS) team, led by Prof Martie Smit and Prof Dirk Opperman in the Department of Microbiology and Biochemistry are conducting exciting research in this area. They filed a patent entitled “Process for the chemical modification of alkanes, fatty acids and fatty alcohols”.  

The invention relates to a process for the enzymatic in-chain hydroxylation of C12 to C16 fatty acids, alcohols, and alkanes. Hydroxylation of C12 fatty acid and alcohol provides routes for the synthesis of “natural” δ-dodecalactone. The advantage of these routes is that they do not rely on massoia lactones. Massoia lactones are derived from the bark of Massoia trees which grow in Indonesia. Harvesting of the bark kills the trees.  

The cytochrome P450 enzymes (P450s) claimed in this patent are to the inventors’ knowledge the most regioselective enzymes described thus far that can be used for the synthesis of δ-dodecalactone from lauric acid or 1-dodecanol. The approach that the technology takes is to claim cytochrome P450 enzymes that share 70 % amino acid identity to a set of selected P450s for the regioselective hydroxylation of lauric acid and 1-dodecanol to synthesise δ-dodecalactone.

Still in early stage

The current state of development is early stage with the technology only demonstrated in the laboratory on a small scale (100-200 ml). Before the technology can be commercialised the team would need to further improve the regioselectivity and stability of the P450s and proof that the reactions can be scaled up in bioreactors. The technology will probably be delivered as an enzyme (amino acid sequence) with the desired properties. 

There are other research groups working on a synthetic biology approach for the de novo synthesis of δ-dodecalactone from glucose by genetically engineered microbes. It is still unclear how such a process will compare in terms of product yields, economics and environmental impact with the processes proposed by the UFS patent.

If the team had to partner with a commercial company, their first choice would be to work with an established flavour and fragrance company. Another possibility would be the small French flavour and fragrance company that Dr Alizé Pennec, the post-doc and co-inventor who initially discovered the unique P450 activity, is working for.

Please view the videos for more information on patents.

The Vice-Rector: Research and Internationalisation has released two new calls for applications for funding. Academic staff and researchers are encouraged to submit applications for these funds. At this stage we are not accepting projects from Research Fellows. 

The two funds are: 

1.  The Industrial Engagement Fund 
2.  The Intellectual Property Commercialisation Fund

Each fund has its own guidelines and application process. The guidelines are attached. The applications must be filled in on RIMS.

The RIMS application forms can be found through this link

For more information please click the documents below:



News Archive

UFS hosts simulation workshop
2012-12-03

Photo: Renè-Jean van der Berg
3 December 2012

The University of the Free State’s School of Nursing, in partnership with the Drexel University’s College of Nursing & Health Profession in Philadelphia in the USA, are hosting a simulation workshop at the Bloemfontein Campus from Monday 26 November – Friday 30 November 2012. The presenters include Prof. Leland Rockstraw, Dr Linda Wilson, Ms Carol Okupniak and Mr John Cornele. These knowledgeable simulation experts run a successful simulation facility for  health-care profession students. Prof. Leland Rockstraw and Dr Linda Wilson have recently published a book on simulation; Ms Carol Okupniak writes a regular column in a journal, Clinical Simulation in Nursing and Mr John Cornele is well known in the USA for presenting exciting workshops on medical moulage. Moulage refers to “medical make-up”

Drexel University has offered this very popular workshop in simulation repeatedly since August 2010 at the Philadelphia Campus. This week’s workshop is the 1st international event and the first simulation training in South Africa. Funding from the Atlantic Philanthropies made it possible for the School of Nursing at the University of the Free State to host the workshop. Participants are educators from different health-care professions from higher educational institutions from most of the provinces in South Africa and from Botswana. The workshop will cover a comprehensive theoretical background of simulation in health professions, best practices and provide an opportunity for hands-on experience in human patient simulation (HPS) and standardized patient (SP). This will be a first for South Africa. Participants will gain insight in learning strategies to promote a clinically safe learning environment and promote adult experiential learning behaviours. 

During this workshop, participants will make use of the new high-fidelity technology in the Authentic Learning facility at the UFS’ School of Nursing.

According to Prof. Yvonne Botma from the UFS School of Nursing, this workshop will equip the health-care profession’s educators with skills to assist their students in linking theory and practice. Simulation will enable students in health care to provide safe patient care with confidence.
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept